Revenue - Additional Information (Details) $ in Millions	1 Months Ended		12 Months Ended
	Oct. 31, 2021 USD ($)	Jul. 31, 2021 USD ($)	Dec. 31, 2022 USD ($) Segment	Dec. 31, 2021 USD ($)	Apr. 30, 2022 USD ($)
Disaggregation Of Revenue [Line Items]
Number of reportable segments | Segment			1
Revenues			$ 0.0
RADx Initiative
Disaggregation Of Revenue [Line Items]
Revenue received in completion of second stage			0.7	$ 7.7
Potential milestone payment	$ 2.0	$ 4.0
Term of contract	Jan. 30, 2022
NIH
Disaggregation Of Revenue [Line Items]
Additional funding available under extension					$ 1.2
Grant revenue recognized			$ 0.5	$ 0.5
Minimum [Member]
Disaggregation Of Revenue [Line Items]
Percentage of product revenue			10.00%